172@29@17@105!~!172@29@0@53!~!|news|tags|alembic-pharma.html|page-2|!~!news|moneycontrol|com!~!|controller|tag.php!~!is_mobile=false
alembic pharma
Jump to
128 Results Found
  • Initiating coverage: HDFC AMC and M&M among 10 stocks that could return 10-40% in 2020 Dec 12, 2019 11:02 AM IST

    Initiating coverage: HDFC AMC and M&M among 10 stocks that could return 10-40% in 2020

    We have collated a list of 10 stocks where different brokerage firms initiated their coverage in December

  • Market Headstart: Nifty50 seen opening flat; Maruti, Ashok Leyland eyed Nov 11, 2019 08:47 AM IST

    Market Headstart: Nifty50 seen opening flat; Maruti, Ashok Leyland eyed

    Trends on SGX Nifty indicate a flat opening for the broader index in India, with a seven-point loss, or 0.06 percent

  • Alembic Pharma gets USFDA nod for Desonide Ointment Oct 24, 2019 11:40 AM IST

    Alembic Pharma gets USFDA nod for Desonide Ointment

    Desonide Ointment, 0.05 per cent, is a low potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses, Alembic Pharmaceuticals sad in a BSE filing.

  • Alembic gets USFDA nod for ointment to treat skin disease Oct 22, 2019 11:45 AM IST

    Alembic gets USFDA nod for ointment to treat skin disease

    The approval by the US Food and Drug Administration (USFDA) is for Clobetasol Propionate topical solution USP, 0.05 per cent, which is therapeutically equivalent to the reference listed drug product Temovate Topical Solution, 0.05 per cent, of Fougera Pharmaceuticals Inc, the company said in a regulatory filing.

  • Hold Alembic Pharma; target of Rs 540: ICICI Direct Jul 31, 2019 04:18 PM IST

    Hold Alembic Pharma; target of Rs 540: ICICI Direct

    ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 540 in its research report dated July 30, 2019.

  • Alembic Pharma Consolidated June 2019 Net Sales at Rs 948.91 crore, up 10.01% Y-o-Y Jul 29, 2019 05:45 PM IST

    Alembic Pharma Consolidated June 2019 Net Sales at Rs 948.91 crore, up 10.01% Y-o-Y

  • Alembic Pharma Standalone June 2019 Net Sales at Rs 896.74 crore, up 10.51% Y-o-Y Jul 29, 2019 04:48 PM IST

    Alembic Pharma Standalone June 2019 Net Sales at Rs 896.74 crore, up 10.51% Y-o-Y

  • Alembic Pharma gets USFDA nod for seizure treatment drug Jul 01, 2019 11:25 AM IST

    Alembic Pharma gets USFDA nod for seizure treatment drug

    Clonazepam orally disintegrating tablet is useful alone or as an adjunct in the treatment of the Lennox-Gastaut syndrome (petit mal variant), akinetic and myoclonic seizures.

  • Alembic Pharma gets USFDA nod for Parkinson's disease treatment drugs Jun 06, 2019 12:16 PM IST

    Alembic Pharma gets USFDA nod for Parkinson's disease treatment drugs

    The approved products are therapeutically equivalent to the reference listed drug Sinemet CR tablets of Merck Sharp & Dohme Corp.

  • Hold Alembic Pharma; target of Rs 560: ICICI Direct May 09, 2019 04:56 PM IST

    Hold Alembic Pharma; target of Rs 560: ICICI Direct

    ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 560 in its research report dated May 09, 2019.

  • Alembic Pharma Consolidated March 2019 Net Sales at Rs 926.95 crore, up 8.63% Y-o-Y May 09, 2019 10:44 AM IST

    Alembic Pharma Consolidated March 2019 Net Sales at Rs 926.95 crore, up 8.63% Y-o-Y

  • Alembic Pharma Standalone March 2019 Net Sales at Rs 848.70 crore, up 1.25% Y-o-Y May 08, 2019 04:31 PM IST

    Alembic Pharma Standalone March 2019 Net Sales at Rs 848.70 crore, up 1.25% Y-o-Y

  • Hold Alembic Pharma; target of Rs 620: ICICI Direct Jan 25, 2019 04:07 PM IST

    Hold Alembic Pharma; target of Rs 620: ICICI Direct

    ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 620 in its research report dated January 23, 2019.

  • Alembic Pharma Consolidated December 2018 Net Sales at Rs 1,018.15 crore, Up 21.21% Y-o-Y. Jan 22, 2019 02:47 PM IST

    Alembic Pharma Consolidated December 2018 Net Sales at Rs 1,018.15 crore, Up 21.21% Y-o-Y.

  • Alembic Pharma Standalone December 2018 Net Sales at Rs 904.72 crore, up 19.84% Y-o-Y Jan 22, 2019 02:47 PM IST

    Alembic Pharma Standalone December 2018 Net Sales at Rs 904.72 crore, up 19.84% Y-o-Y

  • Alembic Pharma Q3 PAT seen up 7.7% YoY to Rs. 140.6 cr: ICICI Direct Jan 11, 2019 05:07 PM IST

    Alembic Pharma Q3 PAT seen up 7.7% YoY to Rs. 140.6 cr: ICICI Direct

    Net Sales are expected to increase by 21.4 percent Y-o-Y (down 9.5 percent Q-o-Q) to Rs. 1019.5 crore, according to ICICI Direct.

  • Hold Alembic Pharma; target of Rs 560: ICICI Direct Oct 24, 2018 03:59 PM IST

    Hold Alembic Pharma; target of Rs 560: ICICI Direct

    ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 560 in its research report dated October 23, 2018.

  • Alembic Pharma Consolidated September 2018 Net Sales at Rs 1,127.06 crore, Up 42.79% Q-o-Q. Oct 22, 2018 02:56 PM IST

    Alembic Pharma Consolidated September 2018 Net Sales at Rs 1,127.06 crore, Up 42.79% Q-o-Q.

  • Alembic Pharma Standalone September 2018 Net Sales at Rs 1,095.43 crore, up 43.76% Q-o-Q Oct 22, 2018 02:40 PM IST

    Alembic Pharma Standalone September 2018 Net Sales at Rs 1,095.43 crore, up 43.76% Q-o-Q

  • Alembic Pharma Q2 PAT may dip 9.3% YoY to Rs. 110 cr: HDFC Securities Oct 17, 2018 06:17 PM IST

    Alembic Pharma Q2 PAT may dip 9.3% YoY to Rs. 110 cr: HDFC Securities

    Net Sales are expected to increase by 18.8 percent Y-o-Y (up 8.7 percent Q-o-Q) to Rs. 940 crore, according to HDFC Securities.

  • Alembic Pharma Q2 PAT may dip 4.5% YoY to Rs. 116.1 cr: ICICI Direct Oct 12, 2018 03:34 PM IST

    Alembic Pharma Q2 PAT may dip 4.5% YoY to Rs. 116.1 cr: ICICI Direct

    Net Sales are expected to increase by 20.7 percent Y-o-Y (up 10.4 percent Q-o-Q) to Rs. 952.3 crore, according to ICICI Direct.

  • Alembic Pharma gets USFDA nod for diabetes drug Sep 14, 2018 06:11 PM IST

    Alembic Pharma gets USFDA nod for diabetes drug

    The company's product is a generic version of Takeda Pharma USA's Kazano tablets, Alembic Pharmaceuticals said in a regulatory filing.

  • Hold Alembic Pharma; target of Rs 525: ICICI Direct Jul 31, 2018 04:11 PM IST

    Hold Alembic Pharma; target of Rs 525: ICICI Direct

    ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 525 in its research report dated July 30, 2018.

  • Alembic Pharma consolidated Jun-2018 sales at Rs 862.53 crore Jul 27, 2018 05:13 PM IST

    Alembic Pharma consolidated Jun-2018 sales at Rs 862.53 crore

    Alembic Pharmaceuticals has reported a consolidated total income from operations of Rs 862.53 crore and a net profit of Rs 90.47 crore for the quarter ended Jun-2018

  • Hold Alembic Pharma; target of Rs 460: ICICI Direct May 24, 2018 05:52 PM IST

    Hold Alembic Pharma; target of Rs 460: ICICI Direct

    ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 460 in its research report dated May 17, 2018.

Sections